| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | translation activator activity | 3.46e-05 | 15 | 12 | 2 | GO:0008494 | |
| GeneOntologyMolecularFunction | translation regulator activity, nucleic acid binding | 1.98e-03 | 112 | 12 | 2 | GO:0090079 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 5.81e-03 | 194 | 12 | 2 | GO:0016705 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | 9.54e-03 | 766 | 12 | 3 | GO:0016491 | |
| GeneOntologyMolecularFunction | mRNA 3'-UTR binding | 1.15e-02 | 276 | 12 | 2 | GO:0003730 | |
| Domain | RRM_1 | 7.57e-03 | 208 | 12 | 2 | PF00076 | |
| Domain | RRM | 8.21e-03 | 217 | 12 | 2 | SM00360 | |
| Domain | RRM_dom | 8.96e-03 | 227 | 12 | 2 | IPR000504 | |
| Domain | RRM | 9.19e-03 | 230 | 12 | 2 | PS50102 | |
| Domain | - | 1.03e-02 | 244 | 12 | 2 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 1.15e-02 | 258 | 12 | 2 | IPR012677 | |
| Pathway | KEGG_LYSINE_DEGRADATION | 4.22e-04 | 44 | 10 | 2 | M13720 | |
| Pathway | REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES | 1.82e-03 | 366 | 10 | 3 | M727 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 1.95e-03 | 95 | 10 | 2 | M48268 | |
| Pathway | KEGG_MELANOGENESIS | 2.20e-03 | 101 | 10 | 2 | M7761 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 4.01e-03 | 137 | 10 | 2 | M48232 | |
| Pathway | WP_MALE_INFERTILITY | 4.48e-03 | 145 | 10 | 2 | M39856 | |
| Pathway | REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES | 1.23e-02 | 245 | 10 | 2 | MM15403 | |
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | 1.61e-04 | 321 | 12 | 3 | 32098917 | |
| Interaction | AGO3 interactions | 8.98e-05 | 153 | 12 | 3 | int:AGO3 | |
| Interaction | BICC1 interactions | 1.22e-04 | 28 | 12 | 2 | int:BICC1 | |
| Interaction | MBNL2 interactions | 1.22e-04 | 28 | 12 | 2 | int:MBNL2 | |
| Interaction | AGO1 interactions | 1.53e-04 | 183 | 12 | 3 | int:AGO1 | |
| Interaction | SECISBP2L interactions | 1.80e-04 | 34 | 12 | 2 | int:SECISBP2L | |
| Interaction | TDRD3 interactions | 2.35e-04 | 212 | 12 | 3 | int:TDRD3 | |
| Interaction | UPF1 interactions | 2.81e-04 | 581 | 12 | 4 | int:UPF1 | |
| Interaction | CELF2 interactions | 3.46e-04 | 47 | 12 | 2 | int:CELF2 | |
| Interaction | PARP12 interactions | 3.76e-04 | 49 | 12 | 2 | int:PARP12 | |
| Interaction | MCRIP2 interactions | 4.08e-04 | 51 | 12 | 2 | int:MCRIP2 | |
| Interaction | RC3H1 interactions | 5.04e-04 | 677 | 12 | 4 | int:RC3H1 | |
| Interaction | MCRIP1 interactions | 5.09e-04 | 57 | 12 | 2 | int:MCRIP1 | |
| Interaction | TNRC6B interactions | 5.43e-04 | 282 | 12 | 3 | int:TNRC6B | |
| Interaction | CSDE1 interactions | 5.54e-04 | 284 | 12 | 3 | int:CSDE1 | |
| Interaction | FBRSL1 interactions | 5.83e-04 | 61 | 12 | 2 | int:FBRSL1 | |
| Interaction | FUBP3 interactions | 6.32e-04 | 297 | 12 | 3 | int:FUBP3 | |
| Interaction | EIF4ENIF1 interactions | 6.50e-04 | 300 | 12 | 3 | int:EIF4ENIF1 | |
| Interaction | CNOT1 interactions | 6.82e-04 | 305 | 12 | 3 | int:CNOT1 | |
| Interaction | YTHDF2 interactions | 7.29e-04 | 312 | 12 | 3 | int:YTHDF2 | |
| Interaction | SMG7 interactions | 7.77e-04 | 319 | 12 | 3 | int:SMG7 | |
| GeneFamily | RNA binding motif containing | 1.35e-03 | 213 | 5 | 2 | 725 | |
| Disease | neutrophil percentage of leukocytes | 2.15e-03 | 610 | 13 | 3 | EFO_0007990 | |
| Disease | chronic obstructive pulmonary disease | 3.03e-03 | 688 | 13 | 3 | EFO_0000341 | |
| Disease | basal cell carcinoma | 3.04e-03 | 189 | 13 | 2 | EFO_0004193 | |
| Disease | eye colour measurement | 4.02e-03 | 218 | 13 | 2 | EFO_0009764 | |
| Disease | biological sex | 4.46e-03 | 230 | 13 | 2 | PATO_0000047 | |
| Disease | Alcoholic Intoxication, Chronic | 6.00e-03 | 268 | 13 | 2 | C0001973 | |
| Disease | psoriasis | 6.22e-03 | 273 | 13 | 2 | EFO_0000676 | |
| Disease | smoking cessation | 8.71e-03 | 325 | 13 | 2 | EFO_0004319 | |
| Disease | platelet-to-lymphocyte ratio | 1.08e-02 | 363 | 13 | 2 | EFO_0008446 | |
| Disease | glucose measurement | 1.17e-02 | 380 | 13 | 2 | EFO_0004468 | |
| Disease | vital capacity | 1.53e-02 | 1236 | 13 | 3 | EFO_0004312 | |
| Disease | cytokine measurement | 1.70e-02 | 461 | 13 | 2 | EFO_0004873 | |
| Disease | lung carcinoma | 1.84e-02 | 482 | 13 | 2 | EFO_0001071 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PAWQGYHPMPHEVEI | 166 | O43310 | |
| NPPSNPYWIMQEHML | 1281 | Q9P241 | |
| PQAYGVPIVFQEPMW | 151 | A0A3B3IT52 | |
| WMQPQPYILQHPGAV | 306 | P29558 | |
| IPMNHLWPNQAPYTV | 701 | Q02218 | |
| GLPQQFPQYQMPMWP | 81 | Q9NRM1 | |
| VYNYQMPPQWPVGEQ | 186 | Q92904 | |
| MPPQWPVGEQRSYVV | 191 | Q92904 | |
| PIGHNRQYNMVPFWP | 431 | P17643 | |
| HPLGWLVPQQGQPMY | 246 | Q9HCS4 | |
| GFAQNPMVPWPPVVH | 1846 | Q92576 | |
| HMIGIGPVLNIYPWN | 311 | Q9NVH6 | |
| PPIQQHIWNMLNPPA | 506 | P13010 | |
| LDIYAQWHHQIPPPM | 1261 | Q86TC9 |